An HPLC/DAD/ESI/MS method was established for the qualitative analysis of the major constituents in Shi-Quan-Da-Bu decoction, a traditional Chinese medicinal formula. Based on the chromatographic separation of most of the constituents of Shi-Quan-Da-Bu decoction on a Zorbax SB-C 18 column with water-acetonitrile as the mobile phase, more than 150 components were detected by LC-MS. Among them, 36 major components, including flavonoids, triterpenoid saponins, iridoid glycosides, phathalides and phenylpropionic acids were either identified or tentatively characterized. Twenty one compounds were identified by ESI-MS and comparison of their retention times with those of reference standards. The other 15 compounds were deduced according to their MS and UV spectra and retention behaviors by comparing the results with those reported in the literature. Most of these compounds were derived mainly from Paeonia lactiflora, Glycyrrhiza uralensis, Panax ginseng, Ligusticum chuanxiong, Angelica sinensis and Astragalus membranaceus.
The use of Traditional Chinese medicine (TCM) for the successful treatment of various diseases has a long history and has attracted more and more attention. TCMs are a very complex mixture containing hundreds or even thousands of components, which make it very arduous and timeconsuming to separate all the single components. Hence it is unwise to use traditional methods for analyzing the major constituents in complex TCM systems.
Efficient detection and rapid characterization of these components on a molecular basis play an increasingly important role as analytical support in scientific studies aimed at a better understanding of the pharmacological actions of TCM.
HPLC fingerprinting is now a widely accepted technique that could cover most of the chemical constituents for quality control of TCM products instead of a few marker compounds [1] . To be valuable and convincing, the fingerprint should have most of its peaks assigned, especially the major ones or the ones which correspond to the effective constituents and toxic ingredients. HPLC coupled with MS could facilitate the assignment in cases when the reference standards necessary for structure identification are lacking. In recent years, our laboratory has made great efforts to apply LC-MS for the compositional analysis of complex TCM systems [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The current paper is the continuation of our research toward this aim.
and produce an anti-tumor effect [18] [19] [20] [21] . It is now widely used in China and Japan as an adjuvant of chemotherapy and radiotherapy. According to the literature [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] , the main constituents of the ten herbal plants include iridoid glycosides, phthalides, terpene glycosides, triterpenes, flavonoids, polysaccharides and volatile oils. However, analysis of the constituents of Shi-QuanDa-Bu decoction has not been reported yet. The current quality control standard is based on the content of the marker compound, paeoniflorin, one of the bioactive compounds in Shi-Quan-Da-Bu decoction [32] . However, this is insufficient for the comprehensive quality control since the effect of the TCM is attributed to the combination of the multiple components of the herbs. This study could assist the deeper understanding of the composition of this TCM.
A newly established HPLC-ESI-MS/MS method was applied for the comprehensive analysis of the constituents of Shi-Quan-Da-Bu decoction. A total of 36 compounds were either identified or tentatively characterized.
By comparing the chromatogram of Shi-Quan-Da-Bu decoction with each single herb extract, the plant source of each peak was confirmed according to the retention time and UV spectra obtained from the DAD detection. It was found that most of the peaks were derived from Paeonia lactiflora, Astragalus membranaceus, Glycyrrhiza uralensis, Panax ginseng, Ligusticum chuanxiong and Angelica sinensis.
The HPLC-ESI-MS assay was applied to Shi-QuanDa-Bu decoction and the six single herbs that mainly contribute to the chromatographic peaks. The ESI-MS spectra were detected in both positive and negative ion modes. The HPLC chromatogram with PDA total scan and total ion current (TIC) profile of the decoction are shown in Figure 1 CN] + was shown in positive ion mode. The information on these ions and a series of fragment ions helped to confirm the molecular weight and accordingly identify the compounds. The (+) ESI-MS and (-) ESI-MS spectral data, and the identification results are shown in Table 1 . [37, 38] . They were characterized as (6αR,11αR)-3-hydroxy-9,10-dimethoxy-pterocarpan-3-O-β-D-glucoside and (6αR,11αR)-3-hydroxy-9,10-dimethoxypterocarpan, respectively. Based on the UV and MS data, and the reference literature [27, 39, 40] , these three components were identified as liquiritin apioside, isoliquiritin apioside and isoliquiritin, respectively.
For the nine ginsenosides, [M-H]
-ions were observed in the (-) ESI-MS and some significant fragment losses in the MS/MS helped to identify their structures. Table 2 shows the MS/MS data for these nine ginsenosides, which were consistent with the reference standards and literature [26, 43] . During the analysis, a noteworthy feature was that one of the major constituents, Rg 3, was detected in some amount in the decoction, but not in the extract of any single herb. Figure 2 gives the MS of several main ginsenosides detected in the decoction with the corresponding ones found in ginseng. The extracted ion chromatogram is shown instead of the total ion current to make the peaks of these ginsenosides outstanding. According to the reported literature [45] [46] [47] , Rg 3 can be prepared from other ginsenosides by, for example, acid hydrolysis, base hydrolysis or streaming at high temperature. Due to the complexity of the constituents in this decoction and the decocting process, it is no wonder that Rg 3 was detected to a certain extent.
Liu et al. had reported that the concentration ratios of major active components detected in individual herbs of P. ginseng and G. uralensis were found to be different from those in Sijunzi decoction [43] . As solubilization, complexation, salification, oxidation, hydrolytic decomposition and reduction usually happens when decocting with other herbs, producing either new compounds or content changing of the herb ingredients is to be expected [48] [49] [50] [51] [52] [53] , which could help clarify the mechanism of compatibility of TCM in vitro. The theory of compound compatibility is the essence in the prescriptions of TCM, hence, it is worth careful and deep research into the changes of the ingredients caused by compatibility.
Experimental
Materials: All the herbs used in this study were purchased from Yang He Tang Co. Ltd. (Shanghai, P. R. China). The reference standards albiflorin, paeoniflorin, ferulic acid, liquiritin, liquiritigenin, isoliquiritigenin, glycyrrhizic acid, cinnamic acid, formononetin, ononin, calycosin, calycosin-7-O-β-Dglucoside, ginsenosides-Rb 1 , -Rb 2 , -Rc, -Rd, -Re, -Rf, -Rg 1 , -Rg 2 , -Rg 3 were obtained from the phytochemistry department in our center. The purity of these standards was more than 98%, based on HPLC analysis.
Acetonitrile was of HPLC grade (Burdick & Jackson, Honeywell International Inc., USA); HPLC grade water was prepared using a Milli-Q water purification system (Millipore, MA, USA). Other chemicals and solvents were all of analytical grade.
Sample preparation:
The ten herbs, of decoction slices, were mixed in equal amounts, except for Glycyrrihiza uralensis, which was one half that of each of the other nine herbs. After soaking in water for 1 h, the mixture was extracted twice with a tenfold amount of water at 100 o C for 1 h. The extracts were combined, filtered, and concentrated to yield a decoction equivalent to 2 g herb per mL. Then 1.5 mL water and 2.5 mL methanol were added to 1 mL decoction to obtain a 50% methanol solution equivalent to 0.4 g herb per mL solution for injection into the HPLC column.
To confirm the origin of the components in ShiQuan-Da-Bu decoction, the extract of crude drugs was prepared for HPLC-DAD and ESI-MS analysis. The extraction processes were as follows: 1 g of each plant was crushed to small pieces and extracted with 10 mL methanol by ultrasonic extraction for 15 min. Then 0.5 mL water was added to 0.5 mL extract to obtain a 50% methanol solution equivalent to 0.05 g herb per mL. All the samples were filtered through a 0.45 μm micropore membrane prior to use. Aliquots of 10 μL of each sample were injected into the HPLC system for analysis.
HPLC conditions: An Agilent 1100 liquid chromatography system, equipped with a quaternary solvent delivery system, an autosampler, a degasser and a DAD detector was used. The mobile phase consisted of (A) acetonitrile and (B) water (v/v) using a gradient elution of 5%-10% A at 0-10 min, 10%-19% A at 10-46 min, 19%-29% A at 46-60 min, 29%-40% A at 60-67 min, and 40%-100% A at 67-95 min. The separation was achieved on a Zorbax SB-C 18 column (250 mm × 4.6 mm, 5 μm) connected to a Zorbax SB-C 18 guard column (20 mm × 4 mm, 5 μm). The mobile phase flow rate was 1.0 mL/min and the column temperature was set at 30°C. The DAD was set to monitor at 203, 230, 280 nm and the on-line UV spectra were recorded in the range 190-400 nm.
HPLC-MS systems:
The HPLC-MS/MS system consisted of a TSQ Quantum triple-quadrupole mass spectrometer interfaced with an electrospray ionization (ESI) probe with a Surveyor LC system controlled by Xcalibur 1.4 controlling software (ThermoElectron, San Jose, CA). The column and elution program were transferred directly from the system described above to this HPLC system. The LC effluent was introduced into the ESI source in a post-column splitting ratio of 2:1 and monitored at the same wavelength as in chromatography. The ESI-MS spectra were acquired in both positive and negative ion modes. The optimized parameters were as follows: in positive ion mode, ion spray voltage, 4 kV; sheath gas (N 2 ) pressure, 35 arbitrary units; auxiliary gas (N 2 ) pressure, 12 units; capillary temperature, 350 o C; collision energy, 35 V; in negative ion mode, ion spray voltage, 3.7 kV; sheath gas (N 2 ) pressure, 30 arbitrary units; auxiliary gas (N 2 ) pressure, 15 units; capillary temperature, 350 o C; collision energy, 50 V. For full-scan MS analysis, the spectra were recorded in the range m/z 145-1300. A data-dependent scan program was used in the liquid chromatography/mass spectrometry analysis so that the most abundant ion in each MS scan was selected and subjected to MS/MS analyses.
Conclusion
Shi-Quan-Da-Bu decoction is a widely used formula to assist curing many asthenic diseases and this paper describes a simple method for the characterization of its major constituents. Using HPLC-DAD coupled with ESI-MS, 36 compounds, including flavonoids, triterpenoid saponins, iridoid glycosides, phathalides and phenylpropionic acids were characterized by comparison of UV and MS spectra with either reference standards or with literature data.
This study provided important chemical support for the quality evaluation and pharmacological study of Shi-Quan-Da-Bu decoction and the high sensitivity and low chromatographic resolution requirement of LC-MS make it a powerful tool in the characterization of constituents in the complex traditional Chinese medicine system.
